Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Human Genetics"
DOI: 10.1038/s10038-019-0681-6
Abstract: In tumor-only next-generation sequencing (NGS), identified variants have the potential to be secondary findings (SFs), but they require verification through additional germline testing. In the present study, 194 patients with advanced cancer who underwent tumor-only… read more here.
Keywords: tp53 variants; tumor next; next generation; generation sequencing ... See more keywords